Kenneth C. Frazier - 02 Mar 2026 Form 4 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Reporting relationship: Director
Issuer ticker: EIKN
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2026, 17:01:49 UTC
Prior SEC filing: 06 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Benjamin Thorner, Attorney-in-Fact

Key filing fact

Kenneth C. Frazier filed Form 4 for Eikon Therapeutics, Inc. (EIKN) on 04 Mar 2026.

Key facts

This page summarizes Kenneth C. Frazier's Form 4 filing for Eikon Therapeutics, Inc. (EIKN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2026, 17:01.

Change

Previous filing in this sequence was filed on 06 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001181175 Primary reporting owner

FRAZIER KENNETH C

Relationship: Director
Address: C/O EIKON THERAPEUTICS, INC., 230 HARRIET TUBMAN WAY, MILLBRAE
Signature: /s/ Benjamin Thorner, Attorney-in-Fact
Signature date: 04 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EIKN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +25,873
Change %
Price: $0.000000^*
Shares after: 25,873
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,873
Exercise price: $14.88
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.